In vitro activity of HR 810, a new cephalosporin.

The in vitro susceptibility of 409 clinical isolates to HR 810, a new cephalosporin, was evaluated and compared with their susceptibility to aztreonam, cefazolin, ceftazidime, imipenem, moxalactam, piperacillin, and gentamicin. On a weight basis, the activity of HR 810 against gram-negative bacilli...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Bertram, M A, Bruckner, D A, Young, L S
Médium: Artigo
Jazyk:Inglês
Vydáno: 1984
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC284139/
https://ncbi.nlm.nih.gov/pubmed/6593000
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky